Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Di | Monopar Therapeutics Inc.: Monopar and NorthStar Amend & Extend Collaboration | 2 | GlobeNewswire (USA) | ||
10.06. | Monopar Therapeutics Inc.: Monopar Presents Data Showcasing the Appeal of uPAR as a Radiopharma Cancer Target and of its lead Clinical Program at the 2024 SNMMI Annual Meeting | 2 | GlobeNewswire (USA) | ||
24.05. | Monopar Therapeutics Inc.: Monopar Announces CFO Succession | 106 | GlobeNewswire (Europe) | WILMETTE, Ill., May 24, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage radiopharmaceutical company focused on developing innovative treatments for cancer patients... ► Artikel lesen | |
09.05. | Monopar Therapeutics Inc.: Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radiopharma Pipeline | 143 | GlobeNewswire (Europe) | Initiated MNPR-101-Zr First-in-Human Phase 1 Radiopharma Clinical Trial MNPR-101-RIT Phase 1 Clinical Trial Targeted for Launch as Early as Q4 2024 or Q1 2025 WILMETTE, Ill., May 09, 2024 (GLOBE NEWSWIRE)... ► Artikel lesen | |
18.04. | Monopar Therapeutics Inc.: Monopar Announces Radiopharma Presentation Selected for Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting | 2 | GlobeNewswire (USA) | ||
10.04. | Monopar Therapeutics Inc.: Monopar Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr in Advanced Cancer Patients | 402 | GlobeNewswire (Europe) | WILMETTE, Ill., April 10, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients... ► Artikel lesen | |
28.03. | Monopar Therapeutics Inc reports results for the quarter ended in December - Earnings Summary | 3 | Reuters | ||
28.03. | Monopar Therapeutics Inc.: Monopar Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Developments | 91 | GlobeNewswire (Europe) | WILMETTE, Ill., March 28, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients... ► Artikel lesen | |
05.03. | Monopar Therapeutics Inc.: Monopar Announces Positive Preclinical Therapeutic Isotope Data for its MNPR-101 Radiopharma Program | 142 | GlobeNewswire (Europe) | WILMETTE, Ill., March 05, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients... ► Artikel lesen | |
27.02. | Monopar Therapeutics Inc.: Monopar Provides Update on MNPR-101-Zr Radiopharma Clinical Trial | 279 | GlobeNewswire (Europe) | WILMETTE, Ill., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients... ► Artikel lesen | |
20.02. | Monopar Therapeutics Inc.: Monopar Receives Clearance to Proceed with First-in-Human Phase 1 Trial of Novel Radiopharmaceutical MNPR-101-Zr in Advanced Cancers | 313 | GlobeNewswire (Europe) | WILMETTE, Ill., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
EVOTEC | 3.856 |
NVIDIA | 2.688 |
TUI | 2.138 |
GAMESTOP | 1.811 |
BAYER | 1.604 |
NEL | 1.533 |
RHEINMETALL | 1.333 |
BYD | 1.159 |
DEUTSCHE LUFTHANSA | 1.036 |
VOLKSWAGEN | 756 |
TESLA | 751 |
CARL ZEISS MEDITEC | 613 |
BASF | 588 |
SNOWFLAKE | 566 |
COMMERZBANK | 561 |
THYSSENKRUPP | 555 |
AIXTRON SE | 547 |
APPLE | 545 |
PORSCHE SE | 543 |
DEFI TECHNOLOGIES | 531 |
SUPER MICRO COMPUTER | 508 |
CAVENDISH HYDROGEN | 488 |
DEUTSCHE BANK | 470 |
MERCEDES-BENZ | 467 |
ALLIANZ | 448 |